[HTML][HTML] MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas

…, Q Mu, P Kroon, Y Zhang, M Galán-Ganga… - Nature …, 2020 - nature.com
Temozolomide (TMZ) is an oral alkylating agent used for the treatment of glioblastoma and
is now becoming a chemotherapeutic option in patients diagnosed with high-risk low-grade …

Role of microvesicles in the spread of herpes simplex virus 1 in oligodendrocytic cells

…, MT Rejas, M Guerra, M Galán-Ganga… - Journal of …, 2018 - Am Soc Microbiol
Herpes simplex virus 1 (HSV-1) is a neurotropic pathogen that can infect many types of cells
and establishes latent infections in the neurons of sensory ganglia. In some cases, the virus …

[HTML][HTML] Cannabinoid receptor CB2 ablation protects against TAU induced neurodegeneration

M Galán-Ganga, C Rodríguez-Cueto… - Acta neuropathologica …, 2021 - Springer
Tauopathies are a group of neurodegenerative diseases characterized by the alteration/aggregation
of TAU protein, for which there is still no effective treatment. Therefore, new …

Cannabinoid CB2 Receptor Modulation by the Transcription Factor NRF2 is Specific in Microglial Cells

M Galán-Ganga, R Del Río, N Jiménez-Moreno… - Cellular and Molecular …, 2020 - Springer
Nuclear factor erythroid 2-related factor 2 (NRF2) is a pleiotropic transcription factor that has
neuroprotective and anti-inflammatory effects, regulating more than 250 genes. As NRF2, …

Role of MSK1 in the induction of NF-κB by the chemokine CX3CL1 in microglial cells

M Galán-Ganga, ÁJ García-Yagüe… - Cellular and molecular …, 2019 - Springer
Microglial cells are essential mediators of neuroinflammatory processes involved in several
pathologies. Moreover, the chemokine fractalkine (CX3CL1) is essential in the crosstalk …

Dianhydrogalactitol overcomes multiple temozolomide resistance mechanisms in glioblastoma

…, AJ Schuhmacher, M Galán-Ganga… - Molecular cancer …, 2021 - AACR
Glioblastoma (GBM) is the most frequent and aggressive primary tumor type in the central
nervous system in adults. Resistance to chemotherapy remains one of the major obstacles in …

MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas.

…, Q Mu, P Kroon, Y Zhang, M Galán-Ganga… - 2020 - repisalud.isciii.es
Temozolomide (TMZ) is an oral alkylating agent used for the treatment of glioblastoma and
is now becoming a chemotherapeutic option in patients diagnosed with high-risk low-grade …

TRANSLATIONAL MODELS TO ADDRESS NEURO-IMMUNE AFFECTATIONS IN SCHIZOPHRENIA

…, LL Molina, A Giralt, M Galan-Ganga… - IBRO Neuroscience …, 2023 - ibroneuroreports.org
Preclinical studies of mental illnesses such as schizophrenia do not have models that
resemble or mimic with sufficient/satisfactory validity the complexity of complex psychiatric …

Impaired signaling of Transcription factors NF-ƘB and NRF2 in CX3CR1-deficient microglia leads to altered neuroinflammation and phagocytosis: implications in …

S Castro-Sánchez, ÁJ García-Yagüe, M Galán-Ganga… - 2018 - digital.csic.es
[Results]: In this study we show that CX3CL1 treatment induced NF-ƘB-p65 and pro-inflammatory
cytokines expression. On the other hand, CX3CR1-deficient primary microglia cells …

Implications of CB2 cannabinoid receptors in the neurodegenerative process associated to tauopathies

M Galán-Ganga, J Merchán-Rubira, F Hernández… - 2018 - digital.csic.es
[Results] We have seen an increase in CB2 expression in hippocampal neurons of 12 month-old
transgenic mice overexpressing hTAUP301S protein. This alteration is an early event …